Gary Pecic

699 total citations
15 papers, 518 citations indexed

About

Gary Pecic is a scholar working on Molecular Medicine, Food Science and Endocrinology. According to data from OpenAlex, Gary Pecic has authored 15 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 12 papers in Food Science and 10 papers in Endocrinology. Recurrent topics in Gary Pecic's work include Antibiotic Resistance in Bacteria (12 papers), Salmonella and Campylobacter epidemiology (12 papers) and Vibrio bacteria research studies (6 papers). Gary Pecic is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Salmonella and Campylobacter epidemiology (12 papers) and Vibrio bacteria research studies (6 papers). Gary Pecic collaborates with scholars based in United States, Italy and Germany. Gary Pecic's co-authors include Jean M. Whichard, Jason P. Folster, Regan Rickert, Maria Sjölund-Karlsson, Shaohua Zhao, Patrick F. McDermott, Amy Krueger, Paula J. Fedorka–Cray, Rebecca L. Howie and Alessandra Carattoli and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Emerging infectious diseases and MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

Gary Pecic

15 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Pecic United States 12 394 341 214 104 87 15 518
Kayode Fashae Nigeria 11 392 1.0× 304 0.9× 264 1.2× 113 1.1× 87 1.0× 14 600
Sunpetch Angkititrakul Thailand 15 286 0.7× 298 0.9× 163 0.8× 162 1.6× 67 0.8× 44 539
Marie Demartin France 9 285 0.7× 348 1.0× 228 1.1× 91 0.9× 45 0.5× 9 460
Patrícia Themudo Portugal 11 266 0.7× 229 0.7× 132 0.6× 115 1.1× 46 0.5× 16 398
Thu-Thuy Tran United States 9 263 0.7× 180 0.5× 154 0.7× 58 0.6× 98 1.1× 9 373
Lance Bolton United States 7 325 0.8× 241 0.7× 184 0.9× 149 1.4× 97 1.1× 8 603
Laura C. Martin Canada 9 227 0.6× 230 0.7× 111 0.5× 109 1.0× 50 0.6× 14 457
Monique Ribeiro Tiba‐Casas Brazil 14 343 0.9× 360 1.1× 274 1.3× 110 1.1× 43 0.5× 55 622
An T.T. Vo Vietnam 7 268 0.7× 224 0.7× 126 0.6× 77 0.7× 42 0.5× 11 369
Inger Olesen Denmark 7 352 0.9× 392 1.1× 218 1.0× 180 1.7× 62 0.7× 7 641

Countries citing papers authored by Gary Pecic

Since Specialization
Citations

This map shows the geographic impact of Gary Pecic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Pecic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Pecic more than expected).

Fields of papers citing papers by Gary Pecic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Pecic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Pecic. The network helps show where Gary Pecic may publish in the future.

Co-authorship network of co-authors of Gary Pecic

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Pecic. A scholar is included among the top collaborators of Gary Pecic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Pecic. Gary Pecic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Krueger, Amy, Sharon A. Greene, Ezra J. Barzilay, et al.. (2014). Clinical Outcomes of Nalidixic Acid, Ceftriaxone, and Multidrug-Resistant Nontyphoidal Salmonella Infections Compared with Pansusceptible Infections in FoodNet Sites, 2006–2008. Foodborne Pathogens and Disease. 11(5). 335–341. 51 indexed citations
2.
Folster, Jason P., Beth Tolar, Gary Pecic, et al.. (2014). Characterization of bla CMY Plasmids and Their Possible Role in Source Attribution of Salmonella enterica Serotype Typhimurium Infections. Foodborne Pathogens and Disease. 11(4). 301–306. 18 indexed citations
3.
Folster, Jason P., Gary Pecic, Steven Stroika, Regan Rickert, & Jean M. Whichard. (2014). Changing plasmid types responsible for extended-spectrum cephalosporin resistance in Escherichia coli O157:H7 in the USA, 1996–2009. Journal of Global Antimicrobial Resistance. 2(2). 87–91. 11 indexed citations
4.
Lindsey, Rebecca L., Jason P. Folster, Gary Pecic, et al.. (2013). Antimicrobial Resistance Genes in Multidrug-Resistant Salmonella enterica Isolated from Animals, Retail Meats, and Humans in the United States and Canada. Microbial Drug Resistance. 19(3). 175–184. 54 indexed citations
5.
Folster, Jason P., Gary Pecic, Aparna Singh, et al.. (2012). Characterization of Extended-Spectrum Cephalosporin–Resistant Salmonella enterica Serovar Heidelberg Isolated from Food Animals, Retail Meat, and Humans in the United States 2009. Foodborne Pathogens and Disease. 9(7). 638–645. 57 indexed citations
6.
Medalla, Felicita, Maria Sjölund-Karlsson, Sanghyuk S. Shin, et al.. (2011). Ciprofloxacin-ResistantSalmonella entericaSerotype Typhi, United States, 1999–2008. Emerging infectious diseases. 17(6). 1095–1098. 6 indexed citations
7.
Folster, Jason P., et al.. (2011). Characterization of bla CMY -Encoding Plasmids Among Salmonella Isolated in the United States in 2007. Foodborne Pathogens and Disease. 8(12). 1289–1294. 47 indexed citations
8.
Folster, Jason P., Gary Pecic, Anna Bowen, et al.. (2011). Decreased Susceptibility to Ciprofloxacin amongShigellaIsolates in the United States, 2006 to 2009. Antimicrobial Agents and Chemotherapy. 55(4). 1758–1760. 41 indexed citations
9.
Medalla, Felicita, Maria Sjölund-Karlsson, Sanghyuk S. Shin, et al.. (2011). Ciprofloxacin-ResistantSalmonella entericaSerotype Typhi, United States, 1999–2008. Emerging infectious diseases. 17(6). 1095–1098. 30 indexed citations
10.
Overman, Michael J., E. Truman Mays, Anna Bowen, et al.. (2010). Notes from the field: emergence of Shigella flexneri 2a resistant to ceftriaxone and ciprofloxacin - South Carolina, October 2010.. MMWR Morbidity and Mortality Weekly Report. 59(49). 7 indexed citations
11.
Sjölund-Karlsson, Maria, Regan Rickert, Gary Pecic, et al.. (2010). Salmonella Isolates with Decreased Susceptibility to Extended-Spectrum Cephalosporins in the United States. Foodborne Pathogens and Disease. 7(12). 1503–1509. 28 indexed citations
12.
Sjölund-Karlsson, Maria, Rebecca L. Howie, Regan Rickert, et al.. (2010). Plasmid-mediated Quinolone Resistance among Non-TyphiSalmonella entericaIsolates, USA. Emerging infectious diseases. 16(11). 1789–1791. 38 indexed citations
13.
Sjölund-Karlsson, Maria, Rebecca L. Howie, Amy Krueger, et al.. (2010). CTX-M–producing Non-TyphiSalmonellaspp. Isolated from Humans, United States. Emerging infectious diseases. 17(1). 97–99. 49 indexed citations
14.
Folster, Jason P., Gary Pecic, Shanna Bolcen, et al.. (2009). Characterization of Extended-Spectrum Cephalosporin–Resistant Salmonella enterica Serovar Heidelberg Isolated from Humans in the United States. Foodborne Pathogens and Disease. 7(2). 181–187. 46 indexed citations
15.
Sjölund-Karlsson, Maria, Jason P. Folster, Gary Pecic, et al.. (2009). Emergence of Plasmid-Mediated Quinolone Resistance among Non-Typhi Salmonella enterica Isolates from Humans in the United States. Antimicrobial Agents and Chemotherapy. 53(5). 2142–2144. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayode Fashae Breakdown of academic impact, for papers by Sunpetch Angkititrakul Breakdown of academic impact, for papers by Marie Demartin Breakdown of academic impact, for papers by Patrícia Themudo Breakdown of academic impact, for papers by Thu-Thuy Tran Breakdown of academic impact, for papers by Lance Bolton Breakdown of academic impact, for papers by Laura C. Martin Breakdown of academic impact, for papers by Monique Ribeiro Tiba‐Casas Breakdown of academic impact, for papers by An T.T. Vo Breakdown of academic impact, for papers by Inger Olesen
Rankless by CCL
2026